Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight
Abstract
The purpose of this study is to describe the safety and efficacy of direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) for the treatment of cancer-associated thrombosis in patients with extreme bodyweights. This was a single center, retrospective cohort study of adult patients on therapy for at least 6 months. The primary efficacy outcome of this study was to describe the time to first recurrent venous thromboembolism (VTE) within 6 months, compared between treatment and across weight cohorts. The primary safety objective was to describe the time to first major bleeding (MB) event within 6 months of starting therapy, between treatment types and among the weight groups. Secondary outcomes included incidence of recurrent VTE, MB, clinically relevant non-major bleeding (CRNMB) and the rate of VTE- or bleeding-related mortality. The time to recurrent VTE was comparable between all groups. In the BMI cohort, the time to first MB was 19.5 times longer for DOACs compared to LMWH in the overweight population (p = 0.007) and to first MB or CRNMB was 11.98 times longer (p = < 0.0001). In the weight cohort, the time to first MB or CRNMB was 14.63 times longer for DOACs compared to LMWH in the overweight population (p = 0.011) and 6.41 times longer in the normal weight population (p = 0.0009). There was an insufficient number of patients in the underweight group to perform statistical analysis. The results suggest that in overweight patients, DOACs have similar…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- What are the causes of late-life depression?
- Identification of SOX3 as an XX male sex reversal gene in mice and humans
- Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome
- Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas
- Metabolic and pathologic profiles of human LSS deficiency recapitulated in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.